Whole-body MRI of multiple myeloma: Comparison of different MRI sequences in assessment of different growth patterns

European Journal of Radiology

Volumn 69, Issue 2, 2009, Pages 339-345

  Weininger, Markus ^a   Lauterbach, Brigitte ^a   Knop, Stefan ^a   Pabst, Thomas ^a   Kenn, Werner ^a   Hahn, Dietbert ^a   Beissert, Matthias ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Durie and Salmon; Multiple myeloma; Plasmocytoma; Whole body MRI

Indexed keywords

CONFIDENCE LEVELS; CONTRAST-ENHANCED; CONTROL GROUPS; DURIE AND SALMON; GROWTH PATTERNS; INITIAL ASSESSMENTS; INTER-OBSERVER VARIABILITIES; MEAN AGES; MRI SCANNERS; MRI SEQUENCES; MULTIPLE MYELOMA; PLASMOCYTOMA; VISUAL DETECTIONS; WHOLE-BODY MRI;

GROWTH (MATERIALS); GROWTH RATE; IMAGE SEGMENTATION; INFILTRATION; SCANNING; SEEPAGE; SOIL MECHANICS;

METHOD OF MOMENTS;

FAT; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROL GROUP; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; MALE; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; WHOLE BODY MRI;

ADULT; AGED; ALGORITHMS; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; WHOLE BODY IMAGING;

EID: 59649121378     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2007.10.025     Document Type: Article

References (32)

1. Durie B.G., Kyle R.A., Belch A., et al. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J 4 (2003) 379-398
2. Barlogie B., Shaughnessy J., Epstein J., et al. Plasma cell myeloma. In: Lichtman M.A., Beutler E., Kipps T.J., Seligsohn U., Kaushansky K., and Prchal J.T. (Eds). Williams hematology. 7th ed. (2006), McGraw-Hill Professional, New York 1501-1533
3. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003;121:749-57.
4. Giuliani N., Rizzoli V., and Roodman G.D. Multiple myeloma bone disease: pathophysiology of osteoblast inhibition. Blood 108 (2006) 3992-3996
5. Matsumoto T., and Abe M. Bone destruction in multiple myeloma. Ann NY Acad Sci 1068 (2006) 319-326
6. Durie B.G., and Salmon S.E. A clinical staging system for multiple myeloma. Cancer 36 (1975) 842-854
7. Durie B.G. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer 42 (2006) 1539-1543
8. Kyle R.A., Schreiman J.S., McLeod R.A., et al. Computer tomography in diagnosis and management of multiple myeloma and its variants. Arch Intern Med 145 (1985) 1451-1452
9. Antoch G., Vogt F.M., Freudenberg L.S., et al. Whole-body dual-modality PET/CT and whole-body MRI for tumour staging in oncology. JAMA 290 (2003) 3199-3206
10. Modic M.T., and Obuchowski N. Whole-body CT screening for cancer and coronary disease: does it pass the test?. Cleve Clin J Med 71 1 (2004) 47-56
11. Durie B.G., Waxman A.D., D'Agnolo A., et al. Whole body F-FDG PET identifies high-risk myeloma. J Nucl Med 43 (2002) 1457-1463
12. Laura R., Cibeira M.T., Uriburu C., et al. Bortezomib: an effective agent in extramedullary disease in multiple myeloma. Eur J Haematol 76 (2006) 405-408
13. Bladé J., Samson D., Reece D., et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 102 (1998) 1115-1123
14. Horger M., Kanz L., Denecke B., et al. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer 109 (2007) 1617-1626
15. Horger M., Claussen C.D., Bross-Bach U., et al. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Eur J Radiol 54 (2005) 289-297
16. Gahrton G., Durie B.G., and Samson D. Multiple myeloma and related disorders. The role of imaging in myeloma (2004), Hodder Arnold, London, UK pp. 155-163
17. Lecouvet F.E., Vande Berg B.C., Michaux L., Jamart J., Maldague B.E., and Malghem J. Development of vertebral fractures in patients with multiple myeloma: does MRI enable recognition of vertebrae that will collapse?. J Comput Assist Tomogr 22 (1998) 430-436
18. Bauer A., Stabler A., Nagel D., et al. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?. Cancer 95 (2002) 1334-1345
19. Walker R., Jones-Jackson L., Rasmussen E., et al. Diagnostic imaging of multiple myeloma-FDG PET and MRI complementary for tracking short vs long term tumour response. Blood 104 (2004) 217a. [abstract #758]
20. Kusumoto S., Jinnai I., Itoh K., et al. Magnetic resonance imaging patterns in patients with multiple myeloma. Br J of Haematol 99 (1997) 649-655
21. Mariette X., Zagdanski A.M., Guermazi A., et al. Prognostic value of vertebral sessions detected by magnetic resonance imaging in patients with stage I multiple myeloma. Br J Haematol 104 (1999) 723-729
22. Baur-Melnyk A., Buhmann S., Durr H.R., and Reiser M. Role of MRI for the diagnosis and prognosis of multiple myeloma. Eur J Radiol 55 (2005) 56-63
23. Mahnken A.H., Wildberger J.E., Gehbauer G., et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR Am J Roentgenol 178 (2002) 1429-1436
24. Schmidt G.P., Reiser M.F., and Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skeletal Radiol 36 (2007) 1109-1119
25. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 20 (1960) 37-46
26. Walker R., Barlogie B., Haessler J., et al. Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol 25 (2007) 1121-1128
27. Hillengass J., Wasser K., Delorme S., et al. Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma. Clin Cancer Res 13 (2007) 475-481
28. Schmidt G.P., Baur A., Stabler A., et al. Estimation of diffuse bone marrow infiltration of the spine in multiple myeloma: correlation of MRT with histological results. ROFO 177 (2005) 745-750
29. Baur A. The diagnosis of plasmocytoma with MRT. Radiologe 40 (2000) 716-722
30. Baur-Melnyk A., and Reiser M. Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography. Radiologe 44 (2004) 874-881
31. Wasser K., Moehler T., Nosas-Garcia S., et al. Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma. ROFO 177 (2005) 1116-1122
32. Baur A., Stabler A., Bartl R., Lamerz R., Scheidler J., and Reiser M. MRI gadolinium enhancement of bone marrow: age-related changes in normals and in diffuse neoplastic infiltration. Skeletal Radiol 26 (1997) 414-418